Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
139
Views
2
CrossRef citations to date
0
Altmetric
Original Research

miR-1306 Promotes Lung Squamous Cell Carcinoma Progression and Predicts Clinical Prognosis of Patients

Mei Li1 Department of Chemotherapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of China
,
Chunxiang Xu2 Department of Orthopedics, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of China
,
Yan Wang3 Department of Radiotherapy, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
&
Hua Liu4 Department of Respiratory, Affiliated Hospital of Nantong University, Nantong, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
Pages 9029-9035 | Published online: 07 Dec 2021

References

  • Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446–454. doi:10.1038/nature2518329364287
  • Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19. doi:10.1007/978-3-319-24223-1_126667336
  • Yamamoto N, Yamanaka T, Ichinose Y, et al. Pooled analysis of S-1 trials in non-small cell lung cancer according to histological type. Anticancer Res. 2010;30(7):2985–2990.20683043
  • Mairinger T. Histology, cytology and molecular diagnostics of lung cancer. Pathologe. 2019;40(6):649–661. doi:10.1007/s00292-019-00677-831602505
  • Jones GS, Baldwin DR. Recent advances in the management of lung cancer. Clin Med. 2018;18(Suppl 2):s41–s46. doi:10.7861/clinmedicine.18-2-s41
  • Liu B, Li J, Cairns MJ. Identifying miRNAs, targets and functions. Brief Bioinform. 2014;15(1):1–19. doi:10.1093/bib/bbs07523175680
  • Khan AQ, Ahmed EI, Elareer NR, Junejo K, Steinhoff M, Uddin S. Role of miRNA-regulated cancer stem cells in the pathogenesis of human malignancies. Cells. 2019;8(8). doi:10.3390/cells8080840
  • Iqbal MA, Arora S, Prakasam G, Calin GA, Syed MA. MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance. Mol Aspects Med. 2019;70:3–20. doi:10.1016/j.mam.2018.07.00330102929
  • Yang S, Sui J, Liu T, et al. Expression of miR-486-5p and its significance in lung squamous cell carcinoma. J Cell Biochem. 2019;120(8):13912–13923. doi:10.1002/jcb.2866530963622
  • Filipska M, Skrzypski M, Czetyrbok K, et al. MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. Lung Cancer. 2018;118:111–118. doi:10.1016/j.lungcan.2018.02.00229571988
  • Walk EE, Yohe SL, Beckman A, et al. The cancer immunotherapy biomarker testing landscape. Arch Pathol Lab Med. 2020;144(6):706–724. doi:10.5858/arpa.2018-0584-CP31714809
  • Chen X, Li C, Li J, Sheng L, Liu X. Upregulation of miR-1306-5p decreases cerebral ischemia/reperfusion injury in vitro by targeting BIK. Biosci Biotechnol Biochem. 2019;83(12):2230–2237. doi:10.1080/09168451.2019.165484631460837
  • He Z-J, Li W, Chen H, Wen J, Gao Y-F, Liu Y-J. miR-1306–3p targets FBXL5 to promote metastasis of hepatocellular carcinoma through suppressing snail degradation. Biochem Biophys Res Commun. 2018;504(4):820–826. doi:10.1016/j.bbrc.2018.09.05930219228
  • Hu Y, Wang L, Gu J, Qu K, Wang Y. Identification of microRNA differentially expressed in three subtypes of non-small cell lung cancer and in silico functional analysis. Oncotarget. 2017;8(43):74554–74566. doi:10.18632/oncotarget.2021829088807
  • Nasim F, Sabath BF, Eapen GA. Lung cancer. Med Clin North Am. 2019;103(3):463–473. doi:10.1016/j.mcna.2018.12.00630955514
  • Kulasingam V, Pavlou MP, Diamandis EP. Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer. Nat Rev Cancer. 2010;10(5):371–378. doi:10.1038/nrc283120383179
  • Huang W, Yan Y, Liu Y, et al. Exosomes with low miR-34c-3p expression promote invasion and migration of non-small cell lung cancer by upregulating integrin α2β1. Signal Transduct Target Ther. 2020;5(1):39. doi:10.1038/s41392-020-0133-y32317629
  • Akhurst T. Staging of non–small-cell lung cancer. PET Clin. 2018;13(1):1–10. doi:10.1016/j.cpet.2017.09.00429157380
  • Ustun F, Tokuc B, Tastekin E, Durmus Altun G. Tumor characteristics of lung cancer in predicting axillary lymph node metastases. Rev Esp Med Nucl Imagen Mol. 2019;38(2):80–86. doi:10.1016/j.remn.2018.09.01030638878
  • Lu Y, Ma T, Wang L, Xue T. Advances in lymph node metastasis and lymph node dissection in early non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2019;22(8):520–525. doi:10.3779/j.issn.1009-3419.2019.08.0731451143
  • Woodard GA, Jones KD, Jablons DM. Lung cancer staging and prognosis. Cancer Treat Res. 2016;170:47–75.27535389
  • Zhu Z, Rong Z, Luo Z, et al. Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis. Mol Cancer. 2019;18(1):126. doi:10.1186/s12943-019-1054-731438963
  • Zheng J, Tan Q, Chen H, et al. lncRNA-SNHG7-003 inhibits the proliferation, migration and invasion of vascular smooth muscle cells by targeting the miR-1306-5p/SIRT7 signaling pathway. Int J Mol Med. 2020;47(2):741–750. doi:10.3892/ijmm.2020.482133416100
  • Salomonsson A, Micke P, Mattsson JSM, et al. Comprehensive analysis of RNA binding motif protein 3 (RBM3) in non-small cell lung cancer. Cancer Med. 2020;9(15):5609–5619. doi:10.1002/cam4.314932491279
  • Kapoor C, Vaidya S, Wadhwan V, Malik S. Lymph node metastasis: a bearing on prognosis in squamous cell carcinoma. Indian J Cancer. 2015;52(3):417–424. doi:10.4103/0019-509X.17675026905157

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.